Weiter zum Inhalt
Toggle navigation
English
English
Favoritenliste (
0
)
(Voll)
Kontakt
Mein Konto
Abmeldung
Mein Konto
Suche
Filter bei nächster Suche beibehalten
topic_facet:"Medical Condition: Atopic Dermatitis MedDRA version: 21.1Level: LLTClassification code 10003639Term: Atopic dermatitisSystem Organ Class: 100000004858;Therapeutic area: Diseases [C] - Skin and Connective Tissue Diseases [C17]"
Erweiterte Suche
Suchverlauf
Struktursuche
Narrative Service
Drug Overviews
Info Guide
/vufind/Search/Results?lookfor=%22Recruitment+Status%3A+Authorised-recruitment+may+be+ongoing+or+finished%22&type=Subject&filter%5B%5D=topic_facet%3A%22Medical+Condition%3A+Atopic+Dermatitis+MedDRA+version%3A+21.1Level%3A+LLTClassification+code+10003639Term%3A+Atopic+dermatitisSystem+Organ+Class%3A+100000004858%3BTherapeutic+area%3A+Diseases+%5BC%5D+-+Skin+and+Connective+Tissue+Diseases+%5BC17%5D%22
/vufind/Search/Results?lookfor=%22Recruitment+Status%3A+Authorised-recruitment+may+be+ongoing+or+finished%22&type=Subject&filter%5B%5D=topic_facet%3A%22Medical+Condition%3A+Atopic+Dermatitis+MedDRA+version%3A+21.1Level%3A+LLTClassification+code+10003639Term%3A+Atopic+dermatitisSystem+Organ+Class%3A+100000004858%3BTherapeutic+area%3A+Diseases+%5BC%5D+-+Skin+and+Connective+Tissue+Diseases+%5BC17%5D%22
Search /vufind/Search2/Results?lookfor=%22Recruitment+Status%3A+Authorised-recruitment+may+be+ongoing+or+finished%22&type=Subject&filter%5B%5D=topic_facet%3A%22Medical+Condition%3A+Atopic+Dermatitis+MedDRA+version%3A+21.1Level%3A+LLTClassification+code+10003639Term%3A+Atopic+dermatitisSystem+Organ+Class%3A+100000004858%3BTherapeutic+area%3A+Diseases+%5BC%5D+-+Skin+and+Connective+Tissue+Diseases+%5BC17%5D%22
PubPharm (88)
1
Tralokinumab monotherapy for adolescent subjects with moderate-to-severe atopic dermatitis - ECZTRA 6 : A randomised, double-blind, placebo-controlled, parallel-group, multi-centre trial to evaluate the efficacy, safety, and tolerability of tralokinumab monotherapy in adolescent subjects with moderate-to-severe atopic dermatitis who are candidates for systemic therapy - ECZTRA 6 (ECZema TRAlokinumab trial no.6)
enthalten in:
WHO International Clinical Trials Registry Platform
| 2023
Wird geladen...
2
Tralokinumab monotherapy for adolescent subjects with moderate-to-severe atopic dermatitis - ECZTRA 6 : A randomised, double-blind, placebo-controlled, parallel-group, multi-centre trial to evaluate the efficacy, safety, and tolerability of tralokinumab monotherapy in adolescent subjects with moderate-to-severe atopic dermatitis who are candidates for systemic therapy - ECZTRA 6 (ECZema TRAlokinumab trial no.6)
enthalten in:
WHO International Clinical Trials Registry Platform
| 2023
Wird geladen...
3
A study to test the safety, pharmacokinetics and efficacy of UCB9741 in healthy study participants and in study participants with atopic dermatitis : Phase 1/2A, randomized, placebo-controlled, single-ascending dose (Part A, participant- and investigator-blind) and repeated-dose (Part B, participant-, investigator-, and sponsor-blind) study to investigate the safety, pharmacokinetics, and efficacy of UCB9741 in healthy study participants (Part A) and in study participants with moderate-to-severe atopic dermatitis (Part B)
enthalten in:
WHO International Clinical Trials Registry Platform
| 2023
Wird geladen...
4
A study to test the safety, pharmacokinetics and efficacy of UCB9741 in healthy study participants and in study participants with atopic dermatitis : Phase 1/2A, randomized, placebo-controlled, single-ascending dose (Part A, participant- and investigator-blind) and repeated-dose (Part B, participant-, investigator-, and sponsor-blind) study to investigate the safety, pharmacokinetics, and efficacy of UCB9741 in healthy study participants (Part A) and in study participants with moderate-to-severe atopic dermatitis (Part B)
enthalten in:
WHO International Clinical Trials Registry Platform
| 2023
Wird geladen...
5
Long-term study to assess the safety and efficacy of Nemolizumab in subjects with Atopic Dermatitis : A Prospective, Multicenter, Long-Term Study to Assess the Safety and Efficacy of Nemolizumab (CD14152) in Subjects with Moderate-to-Severe Atopic Dermatitis
enthalten in:
WHO International Clinical Trials Registry Platform
| 2023
Wird geladen...
6
Long-term study to assess the safety and efficacy of Nemolizumab in subjects with Atopic Dermatitis : A Prospective, Multicenter, Long-Term Study to Assess the Safety and Efficacy of Nemolizumab (CD14152) in Subjects with Moderate-to-Severe Atopic Dermatitis
enthalten in:
WHO International Clinical Trials Registry Platform
| 2023
Wird geladen...
7
Long-term extension trial in subjects with atopic dermatitis who participated in previous tralokinumab trials – ECZTEND : An open-label, single-arm, multi-centre, long-term extension trial to evaluate the safety and efficacy of tralokinumab in subjects with atopic dermatitis who participated in previous tralokinumab clinical trials - ECZTEND
enthalten in:
WHO International Clinical Trials Registry Platform
| 2023
Wird geladen...
8
Long-term extension trial in subjects with atopic dermatitis who participated in previous tralokinumab trials – ECZTEND : An open-label, single-arm, multi-centre, long-term extension trial to evaluate the safety and efficacy of tralokinumab in subjects with atopic dermatitis who participated in previous tralokinumab clinical trials - ECZTEND
enthalten in:
WHO International Clinical Trials Registry Platform
| 2023
Wird geladen...
9
A study to test the safety, pharmacokinetics and efficacy of UCB9741 in healthy study participants and in study participants with atopic dermatitis : Phase 1/2A, randomized, placebo-controlled, single-ascending dose (Part A, participant- and investigator-blind) and repeated-dose (Part B, participant-, investigator-, and sponsor-blind) study to investigate the safety, pharmacokinetics, and efficacy of UCB9741 in healthy study participants (Part A) and in study participants with moderate-to-severe atopic dermatitis (Part B)
enthalten in:
WHO International Clinical Trials Registry Platform
| 2022
Wird geladen...
10
A study to test the safety, pharmacokinetics and efficacy of UCB9741 in healthy study participants and in study participants with atopic dermatitis : Phase 1/2A, randomized, placebo-controlled, single-ascending dose (Part A, participant- and investigator-blind) and repeated-dose (Part B, participant-, investigator-, and sponsor-blind) study to investigate the safety, pharmacokinetics, and efficacy of UCB9741 in healthy study participants (Part A) and in study participants with moderate-to-severe atopic dermatitis (Part B)
enthalten in:
WHO International Clinical Trials Registry Platform
| 2022
Wird geladen...
1
2
3
4
5
6
7
8
9
Nächster »
[9]
Filter & Sortierung
Treffer pro Seite
10
20
50
Sortieren
Relevanz
Neueste zuerst
Älteste zuerst
Verfasser
Zeitschriftentitel
Bibliothek
Standort (Printmedien)
Verwandte Substanzen
Verwandte Substanzen werden ermittelt...
Verwandte Erkrankungen/Symptome
Verwandte Erkrankungen/Symptome werden ermittelt...
Verwandte Gene
Verwandte Gene werden ermittelt...
Systematic Reviews
Clinical Studies
Patente
Covid-19/SARS-CoV-2
Exclude Systematic Reviews
Exclude Clinical Studies
Exclude Patents
Ihre gewählten Filter
Filter bei nächster Suche beibehalten
Filter aufheben
Thema: Medical Condition: Atopic Dermatitis MedDRA version: 21.1Level: LLTClassification code 10003639Term: Atopic dermatitisSystem Organ Class: 100000004858;Therapeutic area: Diseases [C] - Skin and Connective Tissue Diseases [C17]
Medienart
88
Aufsätze
88
E-Artikel
88
E-Ressourcen
Zeitschriftentitel
88
WHO International Clinical Trials Registry Plat...
Thema
88
610
Medical Condition: Atopic Dermatitis MedDRA ver...
88
Recruitment Status: Authorised-recruitment may ...
88
Study Type: Interventional
76
Phase: Phase 3
8
Phase: Phase 1
4
Phase: Phase 2
Alle anzeigen ...
weniger ...
Erscheinungszeitraum
8
2023
42
2022
18
2021
20
2020
Erscheinungsjahr(e)
Von:
Bis:
Sprache
88
Englisch
Haven't found what you're looking for?
Wird geladen...